NRXS
NYSE MKT HealthcareNeuraxis, Inc. Common Stock
Biotechnology
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.
�� 市场数据
| 价格 | $7.22 |
|---|---|
| 成交量 | 228,882 |
| 市值 | 80.77M |
| 贝塔系数 | 1.890 |
| RSI（14日） | 54.7 |
| 200日均线 | $3.86 |
| 50日均线 | $6.28 |
| 52周最高 | $7.97 |
| 52周最低 | $1.55 |
| Forward P/E | -361.00 |
| Price / Book | 22.63 |
🎯 投资策略评分
NRXS 在各投资策略中的评分。分数越高，越符合该策略目标。
🔍 策略解读
最佳匹配： 🚀 Moon Shot (95/100) — 此策略 高增长潜力（高贝塔 + 超卖）.
评分最低的策略： 🐋 Institutional Whale (1/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →
📚 了解更多
在文本中查找 NRXS in your text
粘贴任何文章、记录或帖子 — 工具将提取 NRXS 以及每一个其他隐藏的股票代码。
免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-04-17.